Assisted reproduction cost-effectiveness analysis

被引:0
|
作者
Sarver, RG
机构
关键词
D O I
10.1016/S0090-4295(97)80028-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:656 / 656
页数:1
相关论文
共 50 条
  • [1] Virtual sonographic hysteroscopy in assisted reproduction: A retrospective cost-effectiveness analysis
    Vitale, Salvatore Giovanni
    Lagana, Antonio Simone
    Torok, Peter
    Lasmar, Ricardo Bassil
    Carugno, Jose
    Palumbo, Marco
    Tesarik, Jan
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2022, 156 (01) : 112 - 118
  • [2] Options for Assisted Reproduction in Young Women with Uterine Cancer A Cost-Effectiveness Analysis
    Shah, Monjri M.
    Pier, Bruce D.
    Bouknight, Janet M.
    Straughn, J. Michael, Jr.
    Leath, Charles A., III
    JOURNAL OF REPRODUCTIVE MEDICINE, 2019, 64 (3-4) : 104 - 110
  • [3] OPTIONS FOR ASSISTED REPRODUCTION IN PREMENOPAUSAL WOMEN WITH ENDOMETRIAL CANCER: A COST-EFFECTIVENESS ANALYSIS.
    Pier, B. D.
    Shah, M. M.
    Bouknight, J. M.
    Straughn, J. M.
    Leath, C. A.
    FERTILITY AND STERILITY, 2014, 102 (03) : E153 - E154
  • [4] Is assisted reproduction the optimal treatment for varicocele-associated male infertility? A cost-effectiveness analysis
    Schlegel, PN
    UROLOGY, 1997, 49 (01) : 83 - 90
  • [5] COST-EFFECTIVENESS ANALYSIS OF HCG AND HUMAN GONADOTROPINS IN MEN WITH HYPOGONADOTROPIC HYPOGONADISM IN THE CONTEXT OF AN ASSISTED REPRODUCTION PROGRAM
    Chamberland, C.
    VALUE IN HEALTH, 2014, 17 (03) : A250 - A250
  • [6] WILL COST-EFFECTIVENESS ANALYSIS WORSEN THE COST-EFFECTIVENESS OF CARE
    HIMMELSTEIN, DU
    WOOLHANDLER, S
    BOR, DH
    CLINICAL RESEARCH, 1987, 35 (03): : A744 - A744
  • [7] A cost-effectiveness evaluation of the originator follitropin alpha compared to the biosimilars for assisted reproduction in Germany
    Xue, Weiguang
    Lloyd, Adam
    Falla, Edel
    Roeder, Claudia
    Papsch, Rudiger
    Buehler, Klaus
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2019, 11 : 319 - 331
  • [8] Reflections on the cost-effectiveness of recombinant FSH in assisted reproduction. The clinician's perspective
    Balasch, J
    Barri, PN
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2001, 18 (02) : 45 - 55
  • [10] A cost-effectiveness analysis of buprenorphine-assisted heroin withdrawal
    Doran, CM
    Shanahan, M
    Bell, J
    Gibson, A
    DRUG AND ALCOHOL REVIEW, 2004, 23 (02) : 171 - 175